Navigation Links
Novadaq Data Presented at 2008 Society of Thoracic Surgeons Meeting
Date:1/28/2008

xclusive United States distributor of PLC Medical's CO2 HEART LASER(TM) System for TMR (Trans-Myocardial Revascularization). For more information, please visit the company's website at http://www.novadaq.com.

Forward looking Statements

Certain statements included in this press release may be considered forward-looking. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on Novadaq's current beliefs as well as assumptions made by and information currently available to Novadaq and relate to, among other things, results of future clinical tests of PINPOINT and the SPY System, anticipated financial performance, business prospects, strategies, regulatory developments, market acceptance and future commitments. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by Novadaq in its public securities filings actual events may differ materially from current expectations. Novadaq disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Novadaq Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Novadaqs SPY System receives clearance for use in organ transplant surgery
2. Novadaqs SPY Imaging System named Product of the Year by Frost and Sullivan
3. Novadaq to present at BMO Healthcare Conference
4. Novadaq to present at Piper Jaffray Healthcare Conference
5. Novadaq announces third quarter 2007 conference call and webcast
6. Novadaq launches PINPOINT: Companys first minimally invasive imaging system
7. Novadaq Resumes Normal Business Operations by Securing ICG for SPY
8. Bill Germanakos and Hollie Self Bring The Biggest Loser Million-Pound Tour, Presented by MSN, to Arizona Mills Mall
9. Julie Hadden and Jim Germanakos Bring The Biggest Loser Million-Pound Tour, Presented by MSN, to Towne East Square Mall
10. Once-Daily Exjade(R) Shown to Remove Toxic Iron From the Heart and Liver, According to Data Presented at ASH
11. CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End-of-Phase II Meeting with FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...iday, January 9 , , WASHINGTON, Jan. 8 /PRNews...rnational Union (SEIU) President Andy Stern conven...cutive Board to discuss the forced transfer of 65,...United Healthcare Workers-West (UHW), its third la...til tomorrow. , , According to reports, several...
(Date:1/8/2009)...ape new treatments for secondary pneumonia , , ...Scientists at St. Jude Children,s Research Hospita... bacterial pneumonia following influenza. They fou...in, which kill bacteria by inhibiting their protei...rst-line treatment with the "beta-lactam" antibiot...
(Date:1/8/2009)...search Hospital have demonstrated a more effective...enza. They found that the antibiotics clindamycin ...g their protein synthesis, are more effective than...ctam" antibiotic ampicillin, which causes the bact...tant because pneumonia, rather than the influenza ...
(Date:1/8/2009)...9 Continues Growth Trend , , NORTH HOLLYWOOD, C...spitalist Company, Inc. (Nasdaq: IPCM ), a leadi...ompany, announced today that it has acquired the h...nts, Inc. (MACC) in St. Louis, Missouri. The acqui...ouis market, where IPC has established a significa...
Breaking Medicine News(10 mins):Health News:SEIU Decision to Force Transfer of Long-Term Care Members Out of United Healthcare Workers Delayed 2Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 2Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 3Health News:Study finds more effective treatment for pneumonia following influenza 2Health News:Study finds more effective treatment for pneumonia following influenza 3Health News:IPC The Hospitalist Company Acquires Missouri Practice Group 2
...it brings with it the risk of tick bites and Rocky...illnesses, researchers //are looking at the role p...reen tea and vitamins C and E in preventing infect...nal Institute of Allergy and Infectious Disease, p...
... Center have developed a pioneering genomic test t...ents will need chemotherapy// and which patients c...otentially save thousands of lives by recommending...ently advised against it. The test's promising re...
...che," researchers at the Samsung Medical Center in...ain medication// , following an exercise regimen a...transformed migraines to normal migraine. Transfo... daily headache occurs when individuals begin to e...
...lebrating his 80th birthday at the Thayer Hotel at...e, he will be presented// with the 22nd Joslin Vic...lobal leader in diabetes research, care and educat... type I diabetes for 75 years. Apparently, the hot...
Other Medicine News:Health News:Antioxidants Could Halt Rocky Mountain Spotted Fever 2Health News:New Test For Early-Stage Lung Cancer 2Health News:New Test For Early-Stage Lung Cancer 3Health News:New Test For Early-Stage Lung Cancer 4Health News:Recognition for 75 Years with Type 1 Diabetes!! 2Health News:Recognition for 75 Years with Type 1 Diabetes!! 3
(Date:1/8/2009)... initial dose in an ongoing Phase Ib trial demonst...three days , , Conference Call Today at 8:30AM ...l/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS...f an ongoing Phase Ib clinical trial of ANA598, th...ase inhibitor. ANA598 was very well-tolerated and...
(Date:1/7/2009)...ts in Development Based On Osteotech,s Proprietary...oRegeneration; FDA Filing Anticipated in Third Qua...ire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OST...oducts for regenerative healing, announced today t...its DuraTech(TM) BioRegeneration Matrix. The first...
(Date:1/6/2009)...PRNewswire/ -- In recent controlled studies conduc... , scientists found that the patented ingredient i...ly proven ingredient to increase levels of nitric ...itrate/nitrate (NOx) in human subjects. , , Nit...rease in blood flow to the skeletal muscles. This...
(Date:1/6/2009)...ary 6 , - Early R...n Until,December 2011 , - Expansion of the...iscovery in Ophthalmology , - Revised Comme...ublicenses to a Third Party , ExonHit The...nforcement,of its existing drug discovery collabo...
Breaking Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 2Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Linkwell Corp to File to Extend Filing Date for 2007 Form 10 K 15566 1Linkwell Corp to File to Extend Filing Date for 2007 Form 10 K 15566 2National Press Club to Host NEWSMAKER Media Briefing on Improving the Cost of Healthcare with R Kerry Clark 15563 1Dynatronics Introduces New Synergie Elite Aesthetic Line 15560 1Dynatronics Introduces New Synergie Elite Aesthetic Line 15560 2Medical Mutual of Ohio Earns Top Accreditation for Product Excellence 15557 1Medical Mutual of Ohio Earns Top Accreditation for Product Excellence 15557 2
...03, 2007 /PRNewswire-FirstCall/ --,Phosphagenics L...,intends to initiate a Phase 1b clinical trial to ...d formulation of its transdermal,insulin product, ...e trial is expected to commence in the second quar...ed as a novel "needle-free",way of administering i...
... WIRE)--May 3, 2007 - Xanthus,Pharmaceuticals, Inc...M) reversed the clinical and pathological signs of...clerosis. The presentation,was made by Stephen J. ...t the University of Western Ontario, London, Ontar...ster session at the,59th American Academy of Neuro...
Other Medicine Technology:Phosphagenics to Commence Phase 1b Transdermal Insulin Clinical,Trial in Second Quarter 2Xanthus Presents Novel Approach for Autoimmune Disease Reversal,with Symadex 2Xanthus Presents Novel Approach for Autoimmune Disease Reversal,with Symadex 3
...Single Head Rectangular Camera ,IS2s Single ...ole body scans and SPECT studies. Offering flexibi...ingle Rectangular Head Camera is an ideal camera f...purpose work, and also acquires excellent cardiac ...
...Arctic Circler uses the same cryoconsole and platf...in the pulmonary veins. Arctic Circler is an ablat...liative-only treatments that rely on medication.,...catheter has the ability to create curvilinear les...
...Aneurysm occlusion is the ultimate objective of ne...num coils. With Matrix Detachable Coils, occlusion...ls are intended for embolization of those intracra..., their location, or the patient's general medical...
Tungsten Carbide wire twister.
Medicine Products: